Entities / Person
Todd Davis.
American businessman
- Reports this week
- 2
- Active events
- 0
- Connections
- 11
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
The American Farm Bureau Federation reports on Indiana summer market prices and tracks consumer price index trends.Well supported5 reports
-
Ligand Pharmaceuticals appointed Todd Davis as CEO, acquired a 56% stake in Pelthos Therapeutics Inc., and secured royalty rights on ZELSUVMI sales.Some support4 reports1 development inside
-
Todd Davis joined Monroe Capital LLC as a Director in August 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Todd Davis this week
News at the entities that move Todd Davis most-
Ligand Pharmaceuticals StructuralLigand Pharmaceuticals committed funding and royalty rights to AvenCell Therapeutics, Inc.Moves Todd Davis
-
Indiana StructuralA new agricultural strategy initiative in Indiana was developed in partnership with the Indiana Economic Development Association and supported by Duke Energy.Moves Todd Davis
Connections
The 3 strongest of 11, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Ligand Pharmaceuticals Structural
Todd Davis holds the role of CEO for Ligand Pharmaceuticals.
-
KDE Structural
Todd Davis serves as a division director within KDE.
-
Indiana Structural
Todd Davis functions as Chief Economist for INFB, a role professionally based in the state of Indiana.
History
Events by the month they beganJuly 2026
1 eventJune 2026
3 events- The American Farm Bureau Federation reports on Indiana summer market prices and tracks consumer price index trends.
- Ligand Pharmaceuticals appointed Todd Davis as CEO, acquired a 56% stake in Pelthos Therapeutics Inc., and secured royalty rights on ZELSUVMI sales.
- Todd Davis joined Monroe Capital LLC as a Director in August 2025.